Innophos Holdings, Inc. (NASDAQ:IPHS) has been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation. Innophos’ rating score has improved by 50% from 90 days ago as a result of various analysts’ upgrades and downgrades.
Zacks has also assigned Innophos an industry rank of 100 out of 265 based on the ratings given to related companies.
IPHS has been the subject of a number of research reports. Zacks Investment Research cut shares of Innophos from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. KeyCorp reaffirmed a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st. Finally, BidaskClub raised shares of Innophos from a “sell” rating to a “hold” rating in a research note on Thursday, December 14th.
Shares of Innophos (IPHS) opened at $42.28 on Tuesday. The company has a market cap of $814.75, a PE ratio of 19.48 and a beta of 0.76. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86. Innophos has a one year low of $40.45 and a one year high of $58.22.
TRADEMARK VIOLATION NOTICE: “Analysts Expect Innophos Holdings, Inc. (IPHS) to Post $0.56 EPS” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2018/02/13/analysts-expect-innophos-holdings-inc-iphs-to-post-0-56-eps.html.
Innophos Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.